Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide with Radiotherapy in Diffuse Pontine Gliomas
NCT00514397Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of temozolomide in diffuse intrinsic pontine glioma (DIPG), sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
temozolomide
03
Conditions
diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT00514397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514397.